Scientists test Brand-New COVID vaccine formula in first human volunteers
NCT ID NCT04839146
Summary
This early-stage study tested a new COVID-19 vaccine called ABNCoV2 in 45 healthy adults who had never had COVID-19. The main goals were to check if the vaccine was safe and to find the best dose that creates a strong immune response with minimal side effects. Volunteers received two shots four weeks apart, with researchers carefully monitoring their health and immune system response for several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS COV 2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboud univserity medical center
Nijmegen, Gelderland, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.